A novel splice mutation induces exon skipping of the EXT1 gene in patients with hereditary multiple exostoses

Guo,Xiaoyan; Lin,Mingrui; Yan,Wei; Chen,Wenxu; Hong,Guolin

doi:10.3892/ijo.2019.4688

A novel splice mutation induces exon skipping of the EXT1 gene in patients with hereditary multiple exostoses

Authors:
- Xiaoyan Guo
- Mingrui Lin
- Wei Yan
- Wenxu Chen
- Guolin Hong
View Affiliations

Affiliations: Department of Laboratory Medicine, Fuzhou Second Hospital, Fuzhou, Fujian 350007, P.R. China, Intensive Care Unit, The Affiliated People's Hospital of Fujian Traditional Medical University, Fuzhou, Fujian 350004, P.R. China, Department of Bone Tumors, Fuzhou Second Hospital, Fuzhou, Fujian 350007, P.R. China, Department of Laboratory Medicine, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361003, P.R. China
Published online on: January 16, 2019 https://doi.org/10.3892/ijo.2019.4688
Pages: 859-868
Copyright: © Guo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The molecular mechanism of hereditary multiple exostoses (HME) remains ambiguous and a limited number of studies have investigated the pathogenic mechanism of mutations in patients with HME. In the present study, a novel heterozygous splice mutation (c.1284+2del) in exostosin glycosyltransferase 1 (EXT1) gene was identified in a three‑generation family with HME. Bioinformatics and TA clone‑sequencing indicated that the splice site mutation would result in exon 4 skipping. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) revealed that the expression levels of wild‑type EXT1/EXT2 mRNA in patients with HME were significantly decreased, compared with normal control participants (P<0.05). Abnormal EXT1 transcript lacking exon 4 (EXT1‑DEL) and full‑length EXT1 mRNA (EXT1‑FL) were overexpressed in 293‑T cells and Cos‑7 cells using lentivirus infection. RT‑qPCR demonstrated that the expression level of EXT1‑DEL was significantly increased, compared with EXT1‑FL (17.032 vs. 6.309, respectively; P<0.05). The protein encoded by EXT1‑DEL was detected by western blot analysis, and the level was increased, compared with EXT1‑FL protein expression. Immunofluorescence indicated that the protein encoded by EXT1‑DEL was located in the cytoplasm of Cos‑7 cells, which was consistent with the localization of the EXT1‑FL protein. In conclusion, the present study identified a novel splice mutation that causes exon 4 skipping during mRNA splicing and causes reduced expression of EXT1/EXT2. The mutation in EXT1‑DEL generated a unique peptide that is located in the cytoplasm in vitro, and it expands the mutation spectrum and provides molecular genetic evidence for a novel pathogenic mechanism of HME.

View Figures

View References

1	Stieber JR and Dormans JP: Manifestations of hereditary multiple exostoses. J Am Acad Orthop Surg. 13:110–120. 2005. View Article : Google Scholar : PubMed/NCBI
2	Jones KB: Glycobiology and the growth plate: Current concepts in multiple hereditary exostoses. J Pediatr Orthop. 31:577–586. 2011. View Article : Google Scholar : PubMed/NCBI
3	Wicklund CL, Pauli RM, Johnston D and Hecht JT: Natural history study of hereditary multiple exostoses. Am J Med Genet. 55:43–46. 1995. View Article : Google Scholar : PubMed/NCBI
4	Schmale GA, Conrad EU III and Raskind WH: The natural history of hereditary multiple exostoses. J Bone Joint Surg Am. 76:986–992. 1994. View Article : Google Scholar : PubMed/NCBI
5	Porter DE, Lonie L, Fraser M, Dobson-Stone C, Porter JR, Monaco AP and Simpson AH: Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study. J Bone Joint Surg Br. 86:1041–1046. 2004. View Article : Google Scholar : PubMed/NCBI
6	Porter DE and Simpson AH: The neoplastic pathogenesis of solitary and multiple osteochondromas. J Pathol. 188:119–125. 1999. View Article : Google Scholar : PubMed/NCBI
7	Ahn J, Lüdecke HJ, Lindow S, Horton WA, Lee B, Wagner MJ, Horsthemke B and Wells DE: Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1). Nat Genet. 11:137–143. 1995. View Article : Google Scholar : PubMed/NCBI
8	Hecht JT, Hogue D, Strong LC, Hansen MF, Blanton SH and Wagner M: Hereditary multiple exostosis and chondrosarcoma: Linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. Am J Hum Genet. 56:1125–1131. 1995.PubMed/NCBI
9	Wuyts W and Van Hul W: Molecular basis of multiple exostoses: Mutations in the EXT1 and EXT2 genes. Hum Mutat. 15:220–227. 2000. View Article : Google Scholar : PubMed/NCBI
10	Szuhai K, Jennes I, de Jong D, Bovée JV, Wiweger M, Wuyts W and Hogendoorn PC: Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients. Hum Mutat. 32:E2036–E2049. 2011. View Article : Google Scholar : PubMed/NCBI
11	Jennes I, Pedrini E, Zuntini M, Mordenti M, Balkassmi S, Asteggiano CG, Casey B, Bakker B, Sangiorgi L and Wuyts W: Multiple osteochondromas: Mutation update and description of the multiple osteochondromas mutation database (MOdb). Hum Mutat. 30:1620–1627. 2009. View Article : Google Scholar : PubMed/NCBI
12	Stickens D, Clines G, Burbee D, Ramos P, Thomas S, Hogue D, Hecht JT, Lovett M and Evans GA: The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes. Nat Genet. 14:25–32. 1996. View Article : Google Scholar : PubMed/NCBI
13	McCormick C, Duncan G, Goutsos KT and Tufaro F: The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci USA. 97:668–673. 2000. View Article : Google Scholar : PubMed/NCBI
14	Takei Y, Ozawa Y, Sato M, Watanabe A and Tabata T: Three Drosophila EXT genes shape morphogen gradients through synthesis of heparan sulfate proteoglycans. Development. 131:73–82. 2004. View Article : Google Scholar
15	Zak BM, Schuksz M, Koyama E, Mundy C, Wells DE, Yamaguchi Y, Pacifici M and Esko JD: Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones. Bone. 48:979–987. 2011. View Article : Google Scholar : PubMed/NCBI
16	Jones KB, Piombo V, Searby C, Kurriger G, Yang B, Grabellus F, Roughley PJ, Morcuende JA, Buckwalter JA, Capecchi MR, et al: A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes. Proc Natl Acad Sci USA. 107:2054–2059. 2010. View Article : Google Scholar : PubMed/NCBI
17	Matsumoto K, Irie F, Mackem S and Yamaguchi Y: A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses. Proc Natl Acad Sci USA. 107:10932–10937. 2010. View Article : Google Scholar : PubMed/NCBI
18	Zuntini M, Pedrini E, Parra A, Sgariglia F, Gentile FV, Pandolfi M, Alberghini M and Sangiorgi L: Genetic models of osteochondroma onset and neoplastic progression: Evidence for mechanisms alternative to EXT genes inactivation. Oncogene. 29:3827–3834. 2010. View Article : Google Scholar : PubMed/NCBI
19	Reijnders CM, Waaijer CJ, Hamilton A, Buddingh EP, Dijkstra SP, Ham J, Bakker E, Szuhai K, Karperien M, Hogendoorn PC, et al: No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas. Am J Pathol. 177:1946–1957. 2010. View Article : Google Scholar : PubMed/NCBI
20	Barash Y, Calarco JA, Gao W, Pan Q, Wang X, Shai O, Blencowe BJ and Frey BJ: Deciphering the splicing code. Nature. 465:53–59. 2010. View Article : Google Scholar : PubMed/NCBI
21	Wang GS and Cooper TA: Splicing in disease: Disruption of the splicing code and the decoding machinery. Nat Rev Genet. 8:749–761. 2007. View Article : Google Scholar : PubMed/NCBI
22	Tian C, Yan R, Wen S, Li X, Li T, Cai Z, Li X, Du H and Chen H: A splice mutation and mRNA decay of EXT2 provoke hereditary multiple exostoses. PLoS One. 9:e948482014. View Article : Google Scholar : PubMed/NCBI
23	Chen XJ, Zhang H, Tan ZP, Hu W and Yang YF: Novel mutation of EXT2 identified in a large family with multiple osteochondromas. Mol Med Rep. 14:4687–4691. 2016. View Article : Google Scholar : PubMed/NCBI
24	Bovée JV: Multiple osteochondromas. Orphanet J Rare Dis. 3:32008. View Article : Google Scholar : PubMed/NCBI
25	Wuyts W, Radersma R, Storm K and Vits L: An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas. Clin Genet. 68:542–547. 2005. View Article : Google Scholar : PubMed/NCBI
26	Divina P, Kvitkovicova A, Buratti E and Vorechovsky I: Ab initio prediction of mutation-induced cryptic splice-site activation and exon skipping. Eur J Hum Genet. 17:759–765. 2009. View Article : Google Scholar : PubMed/NCBI
27	Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M and Béroud C: Human Splicing Finder: An online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 37:e672009. View Article : Google Scholar : PubMed/NCBI
28	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
29	Lizée G, Aerts JL, Gonzales MI, Chinnasamy N, Morgan RA and Topalian SL: Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. Hum Gene Ther. 14:497–507. 2003. View Article : Google Scholar : PubMed/NCBI
30	Kobayashi S, Morimoto K, Shimizu T, Takahashi M, Kurosawa H and Shirasawa T: Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus. Biochem Biophys Res Commun. 268:860–867. 2000. View Article : Google Scholar : PubMed/NCBI
31	Xie BB, Li D, Shi WL, Qin QL, Wang XW, Rong JC, Sun CY, Huang F, Zhang XY, Dong XW, et al: Deep RNA sequencing reveals a high frequency of alternative splicing events in the fungus Trichoderma longibrachiatum. BMC Genomics. 16:542015. View Article : Google Scholar : PubMed/NCBI
32	Clement ND and Porter DE: Hereditary multiple exostoses: Anatomical distribution and burden of exostoses is dependent upon genotype and gender. Scott Med J. 59:35–44. 2014. View Article : Google Scholar : PubMed/NCBI
33	Pedrini E, Jennes I, Tremosini M, Milanesi A, Mordenti M, Parra A, Sgariglia F, Zuntini M, Campanacci L, Fabbri N, et al: Genotype-phenotype correlation study in 529 patients with multiple hereditary exostoses: Identification of 'protective' and 'risk' factors. J Bone Joint Surg Am. 93:2294–2302. 2011. View Article : Google Scholar
34	Busse M, Feta A, Presto J, Wilén M, Grønning M, Kjellén L and Kusche-Gullberg M: Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation. J Biol Chem. 282:32802–32810. 2007. View Article : Google Scholar : PubMed/NCBI
35	Bobadilla S, Sunseri N and Landau NR: Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein. Gene Ther. 20:514–520. 2013. View Article : Google Scholar
36	Nukuzuma S, Nakamichi K, Kameoka M, Sugiura S, Nukuzuma C, Miyoshi I and Takegami T: Efficient propagation of progressive multifocal leukoencephalopathy-type JC virus in COS-7-derived cell lines stably expressing Tat protein of human immunodeficiency virus type 1. Microbiol Immunol. 54:758–762. 2010. View Article : Google Scholar